Surrey Heartlands

Joint Formulary & PAD

Solifenacin - Overactive bladder (adults)

You are here : Home > Formulary Search > Solifenacin - Overactive bladder (adults)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Restrictions / Comments :
Important
Preferred
1st line unless contra-indicated
 

Status 2

Green (see narrative)
Formulations :
  • Oral suspension
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
R
Restrictions / Comments :
Important
Only for patients with swallowing difficulties. Prescribe as solifenacin 1mg/ml oral SUSPENSION
 

Status 3

Non Formulary
Formulations :
  • Oral solution
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
NFD1
Restrictions / Comments :
Important
Prescribe as solifenacin 1mg/ml oral SUSPENSION

Documentation

Guidelines (Local)
Selection tool for OAB treatments - Nov 2024
Patient resource
Leaflet-for-trial-of-stopping-OAB-drugs - anticholinergics - Mar 24
Webpage
NICE NG123 Urinary-incontinence-and-pelvic-organ-prolapse-in-women
Webpage
NICE Clinical guideline [CG97] : Lower urinary tract symptoms in men: management
Webpage
LUTS in Men - Management of Overactive Bladder - CKS guidance
Webpage
Urinary incontinence in women - CKS guidelines

PAD Profile

ChemicalSubstance :
Solifenacin
Indication :
Overactive bladder (adults)
Group Name :
Keywords :
antimuscarinics, OAB, urge incontinence, urinary incontinence, urinary frequency, LUTS, urinary urgency, anticholinergics, urinary urgency
Brand Names Include :
Vesicare
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Overactive bladder (adults)
Supporting Documents :
6
Traffic Light Entries :
3

Other Indications

Below are listed other indications that Solifenacin is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Overactive bladder (adults).

Committee Recommendations (2)

06 Mar 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The APC supports patients in trialling a treatment break of their overactive bladder medicines.

A "Leaflet for trial of stopping anticholinergics" can be found in the documents section below.

05 Jul 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

Solifenacin is the 1st line treatment option.

Patients with swallowing difficulties

Solifenacin 1mg/ml oral SUSPENSION sugar free is the preferred option in patients with swallowing difficulties.

Solifenacin 5mg/5ml oral solution is non-formulary due to it being significantly more expensive than the suspension in primary care.

See Selection Tool for locally agreed OAB treatment options